Future work aimed at uncovering these mechanisms, beginning with an examination of the subcellular localization, post-translational modifications, and protein interactions of PGC-1α during muscle atrophy, could produce novel therapeutic strategies to combat pervasive pathological conditions associated with muscle atrophy in patients. Here, PPARGC1A is linked to muscle atrophy.